Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
Completed
National Cancer Institute (NCI)
Phase 3
1996-09-01
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug and giving the drugs in different
combinations may kill more cancer cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of standard combination
chemotherapy treatment with more intensive combination chemotherapy in treating children
with acute lymphocytic leukemia.
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
Completed
Children's Oncology Group
Phase 3
1996-09-01
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining more than one drug and giving the drugs in different
combinations may kill more cancer cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of standard combination
chemotherapy treatment with more intensive combination chemotherapy in treating children
with acute lymphocytic leukemia.
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Completed
National Cancer Institute (NCI)
Phase 3
1996-12-01
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase III trial to compare the effectiveness of combination chemotherapy in
treating children who have relapsed acute lymphoblastic leukemia.
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Completed
Children's Oncology Group
Phase 3
1996-12-01
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase III trial to compare the effectiveness of combination chemotherapy in
treating children who have relapsed acute lymphoblastic leukemia.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
